Skip to main content
Log in

Nuclear Degradation of Particular Fos Family Members Expressed Following Injections of NMDA and Kainate in Murine Hippocampus

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Transient glutamate signaling often leads to long lasting and permanent alterations of a variety of cellular functions through particular membrane receptors in the brain. For elucidation of mechanisms underlying long-term consolidation of transient extracellular signals, we have examined expression and degradation of particular Fos family member proteins required for assembly to the nuclear transcription factor activator protein-1 in this study. Transcription factors could modulate the activity of RNA polymerase II responsible for the formation of mRNA from genomic DNA in the nucleus and therefore regulate de novo synthesis of particular target functional proteins. Mice were intraperitoneally injected with 100 mg/kg N-methyl-D-aspartic acid (NMDA) or 40 mg/kg kainic acid (KA), followed by homogenization of hippocampus in the presence of different protease and phosphatase inhibitors 2 h after administration, and subsequent preparation of nuclear and cytosolic fractions. The systemic administration of both NMDA and KA induced marked expression of particular Fos family members, including c-Fos and Fra-2 proteins, in hippocampal nuclear and cytosolic fractions. Incubation at 30°C for 1 to 18 h led to differential degradation profiles of each Fos family member protein in nuclear fractions in a manner peculiar to the individual excitants. Degradation rate was also affected by dialysis and subsequent addition of inhibitors for phosphatases and proteases. These results suggest that in vivo NMDA and KA signals may additionally modulate the activity of heterologous machineries responsible for breakdown of each Fos family member in a unique manner in nuclear fractions, rather than cytosolic fractions, of murine hippocampus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Abate, C., Marshak, D. R., and Curran, T. 1991. Fos is phosphorylated by p34cdc2, cAMP-dependent protein kinase and protein kinase C at multiple sites clustered within regulatory regions. Oncogene 6:2179–2185.

    Google Scholar 

  2. Anient, F., Papavassiliou, A. G., Knecht, E., and Roche, E. 1996. Selective uptake and degradation of c-Fos and v-Fos by rat liver lysosomes. FEBS Lett. 390:47–52.

    Google Scholar 

  3. Azuma, Y., Ogita, K., and Yoneda, Y. 1996. Particular nuclear transcription factors responsive to systemic administration of kainic acid in murine brain. Neurochem. Int. 29:289–299.

    Google Scholar 

  4. Azuma, Y., Ogita, K. and Yoneda, Y. 1996. Binding of double stranded oligonucleotide probes for particular transcription factors with leucine-zipper motifs in discrete brain structures of mice with acquired and inherent spontaneous seizures. Neurochem. Int. 29:323–333.

    Google Scholar 

  5. Azuma, Y., Ogita, K., and Yoneda, Y. 1999. Constitutive expression of cytoplasmic activator protein-1 with DNA binding activity and responsiveness to ionotropic glutamate signals in the murine hippocampus. Neuroscience 92:1295–1308.

    Google Scholar 

  6. Barber, J. R. and Verma, I. M. 1987. Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12–tetradecanoyl-phorbol-13–acetate and serum. Mol. Cell. Biol. 7:2201–2211.

    Google Scholar 

  7. Bing, G., McMillian, M., Kim, H., Pennypacker, K., Feng, Z., Qi, Q., Kong, L.-Y., Iadarola, M., and Hong, J. S. 1996. Longterm expression of the 35,000 mol. wt. Fos-related antigen in rat brain after kainic acid treatment. Neuroscience 73:1159–1174.

    Google Scholar 

  8. Chen, R.-H., Abate, C., and Blenis, J. 1993. Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90–kDa ribosomal S6 kinase. Proc. Natl. Acad. Sci. U.S.A. 90:10952–10956.

    Google Scholar 

  9. Ciechanover, A., DiGiuseppe, J. A., Bercovich, B., Orian, A., Richter, J. D., Schwartz, A. L., and Brodeur, G. M. 1991. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc. Natl. Acad. Sci. U.S.A. 88:139–143.

    Google Scholar 

  10. Curran, T. and Franza, B. R. Jr. 1988. Fos and Jun: the AP1 connection. Cell 55:395–397.

    Google Scholar 

  11. Deng, T. and Karin, M. 1994. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 371:171–175.

    Google Scholar 

  12. Hermida-Matsumoto, M. L., Chock, P. B., Curran, T., and Yang, D. C. 1996. Ubiquitinylation of transcription factors c-Jun and c-Fos using reconstituted ubiquitinylating enzymes. J. Biol. Chem. 271:4930–4936.

    Google Scholar 

  13. Kaminska, B., Filipkowski, R. K., Zurkowska, G., Lason, W., Przewlocki, G., and Kaczmarek, L. 1994. Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following kainate-induced seizures and cell death. Eur. J. Neurosci. 6:1558–1566.

    Google Scholar 

  14. Le Gal La Salle, G. 1988. Long-lasting and sequential increase of c-fos oncoprotein expression in kainic acid-induced status epilepticus. Neurosci. Lett. 88:127–130.

    Google Scholar 

  15. Manabe, T., Kitayama, T., Ogita, K., and Yoneda, Y. 2000. Differential expression and phosphorylation of particular Fos family members by kainic acid in nuclear and cytosolic fractions of murine hippocampus. Neuroscience 100:453–463.

    Google Scholar 

  16. Mandelzys, A., Gruda, M. A., Bravo, R., and Morgan, J. I. 1997. Absence of a persistently elevated 37 kDa Fos-related antigen and AP-1–like DNA-binding activity in the brains of kainic acid-treated fosB null mice. J. Neurosci. 15:5407–5415.

    Google Scholar 

  17. Ofir, R., Dwarki, V. J., Rasshid, D., and Verma, I. M. 1990. Phosphorylation of the C-terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter. Nature 348:80–82.

    Google Scholar 

  18. Ogita, K. and Yoneda, Y. 1994. Selective potentiation of DNA binding activities of both activator protein-1 and cyclic AMP response element binding protein through in vivo activation of N-methyl-D-aspartate receptor complex in mouse brain. J. Neurochem. 63:525–534.

    Google Scholar 

  19. Pennypacker, K. R., Thai, L., Hong, J.-S., and McMillan, M. K. 1994. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment. J. Neurosci. 14:3998–4006.

    Google Scholar 

  20. Popovici, T., Represa, A., Crepel, V., Barbin, G., Beadoin, M., and Ben-Ari, Y. 1990. Effects of kainic acid-induced seizures and ischemia on c-fos-like proteins in rat brain. Brain Res. 536:183–194.

    Google Scholar 

  21. Sakurai-Yamashita, Y., Sassone-Corsi, P., and Gombos, G. 1991. Immunohistochemistry of c-fos in mouse brain during postnatal development: basal levels and changing response to metrazol and kainate. Eur. J. Neurosci. 3:764–770.

    Google Scholar 

  22. Sassone-Corsi, P., Sisson, J. C., and Verma, I. M. 1988. Transcriptional autoregulation of the proto-oncogene fos. Nature 334:314–319.

    Google Scholar 

  23. Schreiber, E., Matthias, P., Muller, M. M., and Schaffner, W. 1989. Rapid detection of octamer binding proteins with "miniextract", prepared from a small number of cells. Nucleic Acids Res. 17:6419.

    Google Scholar 

  24. Sonnenberg, J. L., Mitchelmore, C., Macgregor-Leon, P. F., Hempstead, J., Morgan, J. I., and Curran, T. 1989. Glutamate receptor agonists increase the expression of Fos, Fra, and AP-1 DNA binding activity in the mammalian brain. J. Neurosci. Res. 24:72–80.

    Google Scholar 

  25. Stancovski, I., Gonen, H., Orian, A., Schwartz, A. L., and Ciechanover, A. 1995. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugated enzymes. Mol. Cell Biol. 15:7106–7116.

    Google Scholar 

  26. Tratner, I., Ofir, R., and Verma, I. M. 1992. Alteration of a cyclic AMP-dependent protein kinase phosphorylation site in the c-Fos protein augments its transforming potential. Mol. Cell Biol. 12:998–1006.

    Google Scholar 

  27. Yoneda, Y. and Ogita, K. 1989. Microbial methodological artifacts in [3H]glutamate receptor binding assays. Anal. Biochem. 177:250–255.

    Google Scholar 

  28. Yoneda, Y. and Ogita, K. 1994. Rapid and selective enhancement of DNA binding activity of the transcription factor AP1 by systemic administration of N-methyl-D-aspartate in murine hippocampus. Neurochem. Int. 25:263–271.

    Google Scholar 

  29. Yoneda, Y., Ogita, K., Azuma, Y., Ikeda, M., Tagami, H., and Manabe, T. 1999. N-Methyl-D-aspartate signaling to nuclear activator protein-1 through mechanisms different from those for kainate signaling in murine hippocampus. Neuroscience 90:519–533.

    Google Scholar 

  30. Yoneda, Y., Ogita, K., Azuma, Y., Kuramoto, N., Manabe, T., and Kitayama, T. 1999. Predominant expression of nuclear activator protein-1 complex with DNA binding activity following systemic administration of N-methyl-D-aspartic acid in dentate granule cells of murine hippocampus. Neuroscience 93:19–31.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamichi, N., Manabe, T. & Yoneda, Y. Nuclear Degradation of Particular Fos Family Members Expressed Following Injections of NMDA and Kainate in Murine Hippocampus. Neurochem Res 27, 131–138 (2002). https://doi.org/10.1023/A:1014866909035

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014866909035

Navigation